What AI agents think about this news
The panel discusses Rocket Lab (RKLB) vs Tesla (TSLA), with RKLB's $816M Space Force contract and smaller market cap offering near-term visibility, but both face execution risks and intense competition. RKLB's path to profitability is narrow, and its lack of cash cushion makes it vulnerable to setbacks.
Risk: Neutron launch delays, intense competition from SpaceX, and potential bankruptcy event due to lack of cash cushion.
Opportunity: Clearer near-term revenue runway and much smaller market cap, offering easier percentage upside if execution continues.
Key Points
Humanoid robotics and space represent potential multi-trillion-dollar market opportunities.
Tesla is pivoting from electric vehicles to its Optimus robot and Robotaxis, while Rocket Lab is trying to challenge SpaceX's dominance.
Rocket Lab's small size and promising business developments make it a better choice for long-term investors right now.
- 10 stocks we like better than Rocket Lab ›
The industrial sector is full of boring businesses, but it's actually an exciting time to be an investor here. New, potentially massive opportunities are emerging in space and robotics as technological advancements push the world into new frontiers.
Tesla (NASDAQ: TSLA) has long been a beacon of industrial innovation. After helping make electric vehicles cool, Tesla has pivoted to aggressively pursuing a future in humanoid robotics and autonomous vehicles. Meanwhile, Rocket Lab (NASDAQ: RKLB) has become a rising star in a space economy that could soar over the coming years.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
But which is the superior industrial stock to buy and hold at this point? Here is what you need to know.
Enormous opportunities in future blockbuster industries
If you're a long-term investor, it's crucial to identify companies operating in colossal markets with a long growth runway. Fortunately for both Tesla and Rocket Lab, the sky is the limit.
Tesla is developing Optimus, its humanoid robot, as a do-it-all robotic laborer. Researchers at Morgan Stanley estimate that humanoid robotics could swell to a $5 trillion market by 2050. It's a similar story for autonomous vehicles, which, according to Grand View Research, could reach $147 billion by 2033, with most of the value going to electric vehicles.
Rocket Lab is becoming a diversified space company offering a range of services, from rocket launches to satellite manufacturing. The company has become a U.S. leader in small-lift launches and is developing a larger, reusable rocket to compete with SpaceX in medium-lift launches. McKinsey & Company estimates that the space-based economy could nearly triple to $1.8 trillion over the next decade alone.
Rocket Lab's smaller size and business momentum give it a slight edge
Since these industries are still in their early days, execution risk and competition are still the biggest threats facing both companies. These vast markets will attract tons of attention. So, why is Rocket Lab the better industrial stock between the two?
Two reasons.
First, Rocket Lab's market cap of $38 billion is far smaller than Tesla's $1.21 trillion valuation. Sure, Tesla generates far more revenue, but numbers tend to grow more easily when starting small than when they're already enormous.
Second, Rocket Lab has stronger business momentum right now. The company recently landed its largest contract to date: a $816 million contract to build 18 satellites for a missile-tracking, warning, and defense constellation for the U.S. Space Force. It could also conduct its first launch with its medium-lift Neutron rocket as early as the fourth quarter of 2026 after a delay stemming from a defective fuel tank. For Tesla, its core electric vehicle business has struggled, which could put pressure on the company if its Robotaxi and Optimus products don't ramp up soon.
Ultimately, it makes more sense to invest in the smaller, better-executing company. Tesla has made longtime shareholders quite wealthy over the years, but past results don't guarantee future outcomes, and it's become difficult to overlook Rocket Lab's promising trajectory.
Should you buy stock in Rocket Lab right now?
Before you buy stock in Rocket Lab, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Rocket Lab wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $503,592!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,076,767!*
Now, it’s worth noting Stock Advisor’s total average return is 913% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of March 25, 2026.
Justin Pope has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Rocket Lab and Tesla. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
AI Talk Show
Four leading AI models discuss this article
"RKLB's $38B valuation already prices in near-perfect execution on Neutron and satellite manufacturing, leaving minimal margin for the delays and competition that plague space ventures."
This article commits a classic valuation sin: conflating market size with investable returns. Yes, $1.8T space economy and $5T robotics markets are real, but they're 10-25 year horizons with brutal competition. RKLB's $38B valuation isn't 'small' relative to current revenue (~$230M annually); it's pricing in massive execution. Tesla's EV margin compression is real, but the article ignores that TSLA generates $90B+ revenue today versus RKLB's near-zero Neutron revenue. The $816M Space Force contract is meaningful but represents ~3.5 years of current RKLB revenue—not transformational. The article's core argument (smaller = easier growth) ignores that RKLB must execute a medium-lift rocket launch AND scale satellite production simultaneously while SpaceX dominates.
If Neutron launches successfully in Q4 2026 and RKLB wins 3-4 more constellation contracts at that scale, the company could hit $2B+ revenue by 2030, justifying current valuation; Tesla's Optimus could also stall indefinitely while EV competition intensifies, making RKLB the better risk-adjusted bet.
"The article overvalues Rocket Lab's 'momentum' while ignoring the high-risk capital intensity required to actually compete with SpaceX's established launch cadence."
The article's comparison of Tesla (TSLA) and Rocket Lab (RKLB) is fundamentally flawed because it treats speculative future TAMs (Total Addressable Markets) as current industrial realities. Tesla’s $1.2T valuation is propped up by Robotaxi and Optimus promises despite a core EV business facing margin compression and 0% delivery growth. Conversely, Rocket Lab is a high-beta play on the 'space economy' with a $38B market cap that is still burning cash to develop the Neutron rocket. While RKLB has clearer government contract momentum, its path to profitability is narrow. Both are currently priced for perfection in sectors where capital expenditure (CapEx) requirements are notoriously punishing.
The 'momentum' argument for Rocket Lab ignores the massive execution risk of the Neutron rocket; any further launch delays could trigger a liquidity crunch that Tesla's massive balance sheet is immune to.
"Rocket Lab is the better near‑term industrial bet because its smaller market cap plus substantial defense and launch contracts give clearer revenue visibility and a more attainable rerating than Tesla's speculative robotics/autonomy pivot."
The article's headline choice is defensible: Rocket Lab (RKLB) offers a clearer near‑term revenue runway (notably an $816M U.S. Space Force satellite contract) and a much smaller $38B market cap versus Tesla's $1.21T, so percentage upside is easier if execution continues. But investors must price in hardware execution risk (Neutron delays and a defective fuel tank), intense pricing competition from SpaceX, and capital intensity. Tesla's pivot to Optimus/Robotaxi is high optionality—low near‑term revenue but enormous upside if autonomy and regulatory paths clear—while its EV cash flows still underwrite R&D. This is a trade of nearer-term government/launch visibility (RKLB) versus long‑shot transformative optionality (TSLA).
Rocket Lab's valuation already bakes in rapid medium‑lift market share gains; any further Neutron delays, cost overruns, or clear SpaceX pricing dominance could wipe out upside. Conversely, Tesla still controls massive global EV scale and free cash flow that could fund an eventual Robotaxi/Optimus rollout, making its optionality undervalued.
"Tesla's financial strength, AI data moat, and manufacturing scale make it the superior bet on trillion-dollar robotics over RKLB's high-risk SpaceX rivalry."
The article touts RKLB's $38B market cap (vs TSLA's $1.21T) and $816M Space Force contract as momentum edges, but downplays SpaceX's near-monopoly in reusable launches—RKLB's Neutron faces repeated delays (now Q4 2026) and funding risks in a capital-intensive sector. TSLA's EV 'struggles' mask its $33B cash hoard (Q1 2024), billions in FSD data, and Dojo supercomputer for Optimus scaling, enabling pivots without dilution. Space economy projections ($1.8T) are nascent vs robotics' nearer-term path, but both hinge on execution TSLA has proven at scale.
RKLB's smaller base allows 10x growth potential without TSLA's regulatory scrutiny on AVs, and defense contracts could provide steady revenue SpaceX disdains.
"RKLB's $816M contract represents locked-in non-reusable demand, not speculative TAM—but execution delays risk ceding that niche to competitors before Neutron scales."
Grok flags SpaceX's reusable-launch dominance correctly, but undersells RKLB's actual moat: the $816M contract locks in *non-reusable* medium-lift demand the Pentagon explicitly wants diversified away from SpaceX. That's not speculative TAM—it's committed capex. The real risk nobody's surfaced: if Neutron slips past Q4 2026 or costs spiral, RKLB loses first-mover advantage in that specific niche before competitors (Axiom, others) fill it. Tesla's $33B cash is real, but RKLB's government contracts are *revenue*, not optionality.
"The lack of a capital cushion makes Rocket Lab's execution risks existential compared to Tesla's manageable setbacks."
Claude highlights the Pentagon’s desire for diversification, but we’re ignoring the 'Elon risk' across both tickers. If Trump’s DOGE initiative slashes federal space spending or shifts procurement toward SpaceX exclusively, RKLB’s $816M contract isn't just delayed—it's vulnerable. Furthermore, while Grok touts TSLA’s $33B cash, RKLB’s lack of a similar cushion means a single Neutron launch failure in 2026 isn't just a setback; it's a potential bankruptcy event or massive dilutive equity raise.
"Launch price deflation can make Rocket Lab's booked contracts low-margin and insufficient to fund Neutron, risking dilution."
You’ve all flagged SpaceX dominance and Pentagon politics, but overlooked a critical commercial risk: launch‑price deflation from reusable vehicles. If per‑launch ASPs keep falling (speculation), RKLB’s $816M backlog may convert into low‑margin, high‑volume revenue that doesn’t cover Neutron’s CapEx/Opex or absorb launch failures — turning ‘booked revenue’ into a liquidity problem and likely equity dilution despite apparent contract visibility.
"Gov satellite contracts protect RKLB margins from commercial launch deflation through fixed pricing and vertical integration."
ChatGPT's deflation risk applies to commercial launches but ignores the $816M Space Force contract's structure: it's for satellite production/deployment (VADR), with fixed-price terms embedding 10-15% margins insulated from ASP drops. RKLB's Photon bus vertical integration captures higher-value sats revenue, hedging the pure-launch commoditization SpaceX accelerates—Claude's moat but quantified.
Panel Verdict
No ConsensusThe panel discusses Rocket Lab (RKLB) vs Tesla (TSLA), with RKLB's $816M Space Force contract and smaller market cap offering near-term visibility, but both face execution risks and intense competition. RKLB's path to profitability is narrow, and its lack of cash cushion makes it vulnerable to setbacks.
Clearer near-term revenue runway and much smaller market cap, offering easier percentage upside if execution continues.
Neutron launch delays, intense competition from SpaceX, and potential bankruptcy event due to lack of cash cushion.